<DOC>
	<DOC>NCT00150358</DOC>
	<brief_summary>To assess changes with respect to Erectile Dysfunction in subjects treated with Viagra and antihypertensive therapy.</brief_summary>
	<brief_title>To Yield Further Information On The Efficacy And Safety Of Viagra Among Subjects With Arterial Hypertension .</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>Subjects with arterial hypertension treated with one or more antihypertensive agents, the doses of which have been stable for at least 4 weeks prior to the baseline visit, with a documented clinical diagnosis of ED and a confirmation of this by a qualification of 21 or less on the SHIM. Subjects with resting sitting systolic blood pressure &gt;170 or &lt;110mmHg or resting sitting diastolic blood pressure &gt;90 or &lt;50mmHg, with significant cardiovascular disease and retinitis pigmentosa, treatment with nitrates, alfablockers or CYP3A4 inhibitors.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2006</verification_date>
</DOC>